333 related articles for article (PubMed ID: 32799884)
1. Oncometabolites and the response to radiotherapy.
Xiang K; Jendrossek V; Matschke J
Radiat Oncol; 2020 Aug; 15(1):197. PubMed ID: 32799884
[TBL] [Abstract][Full Text] [Related]
2. Linking Cancer Metabolism to DNA Repair and Accelerated Senescence.
Efimova EV; Takahashi S; Shamsi NA; Wu D; Labay E; Ulanovskaya OA; Weichselbaum RR; Kozmin SA; Kron SJ
Mol Cancer Res; 2016 Feb; 14(2):173-84. PubMed ID: 26538285
[TBL] [Abstract][Full Text] [Related]
3. A systems approach to predict oncometabolites via context-specific genome-scale metabolic networks.
Nam H; Campodonico M; Bordbar A; Hyduke DR; Kim S; Zielinski DC; Palsson BO
PLoS Comput Biol; 2014 Sep; 10(9):e1003837. PubMed ID: 25232952
[TBL] [Abstract][Full Text] [Related]
4. Metabolite sensing and signaling in cancer.
Wang YP; Li JT; Qu J; Yin M; Lei QY
J Biol Chem; 2020 Aug; 295(33):11938-11946. PubMed ID: 32641495
[TBL] [Abstract][Full Text] [Related]
5. Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.
Morin A; Letouzé E; Gimenez-Roqueplo AP; Favier J
Int J Cancer; 2014 Nov; 135(10):2237-48. PubMed ID: 25124653
[TBL] [Abstract][Full Text] [Related]
6. Oncometabolites: tailoring our genes.
Nowicki S; Gottlieb E
FEBS J; 2015 Aug; 282(15):2796-805. PubMed ID: 25864878
[TBL] [Abstract][Full Text] [Related]
7. Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response.
Toulany M
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30621219
[TBL] [Abstract][Full Text] [Related]
8. Oncometabolites-A Link between Cancer Cells and Tumor Microenvironment.
Baryła M; Semeniuk-Wojtaś A; Róg L; Kraj L; Małyszko M; Stec R
Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205136
[TBL] [Abstract][Full Text] [Related]
9. Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory.
Collins RRJ; Patel K; Putnam WC; Kapur P; Rakheja D
Clin Chem; 2017 Dec; 63(12):1812-1820. PubMed ID: 29038145
[TBL] [Abstract][Full Text] [Related]
10. Oncometabolites: Unconventional triggers of oncogenic signalling cascades.
Sciacovelli M; Frezza C
Free Radic Biol Med; 2016 Nov; 100():175-181. PubMed ID: 27117029
[TBL] [Abstract][Full Text] [Related]
11. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies.
Ambrosini G; Cordani M; Zarrabi A; Alcon-Rodriguez S; Sainz RM; Velasco G; Gonzalez-Menendez P; Dando I
Cell Commun Signal; 2024 Jan; 22(1):36. PubMed ID: 38216942
[TBL] [Abstract][Full Text] [Related]
12. Oncometabolites in cancer aggressiveness and tumour repopulation.
Dando I; Pozza ED; Ambrosini G; Torrens-Mas M; Butera G; Mullappilly N; Pacchiana R; Palmieri M; Donadelli M
Biol Rev Camb Philos Soc; 2019 Aug; 94(4):1530-1546. PubMed ID: 30972955
[TBL] [Abstract][Full Text] [Related]
13. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
14. A New Twist in Protein Kinase B/Akt Signaling: Role of Altered Cancer Cell Metabolism in Akt-Mediated Therapy Resistance.
Götting I; Jendrossek V; Matschke J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202866
[TBL] [Abstract][Full Text] [Related]
15. The CD73/Ado System-A New Player in RT Induced Adverse Late Effects.
de Leve S; Wirsdörfer F; Jendrossek V
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623231
[TBL] [Abstract][Full Text] [Related]
16. From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy.
Di Gregorio E; Miolo G; Saorin A; Steffan A; Corona G
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070384
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
[TBL] [Abstract][Full Text] [Related]
18. DNA repair targeting and radiotherapy: a focus on the therapeutic ratio.
Thoms J; Bristow RG
Semin Radiat Oncol; 2010 Oct; 20(4):217-22. PubMed ID: 20832013
[TBL] [Abstract][Full Text] [Related]
19. Oncometabolites in Cancer: Current Understanding and Challenges.
Liu Y; Yang C
Cancer Res; 2021 Jun; 81(11):2820-2823. PubMed ID: 33762356
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
